Kodipar (Paracetamol, Codeine Phosphate Hemihydrate)

Kodipar, containing paracetamol and codeine, acts on pain pathways and the thermoregulatory centre to relieve discomfort and lower temperature.

• Mild to moderate pain: provides effective analgesia for conditions such as headache, dental pain or musculoskeletal aches.
• Fever: reduces elevated body temperature associated with infections or inflammatory states.
• Post‑operative discomfort: helps manage pain after minor surgical procedures.

• Paracetamol inhibits central cyclooxygenase enzymes, decreasing prostaglandin synthesis and thereby reducing pain and fever. Codeine phosphate hemihydrate is an opioid agonist that binds to µ‑opioid receptors in the central nervous system, modulating pain perception and producing mild sedation.

Kodipar may cause a range of adverse reactions, from common, mild events to rare but serious conditions.

Common Side Effects

• Nausea: occasional upset stomach or urge to vomit.
• Constipation: reduced bowel movements, especially with prolonged use.
• Drowsiness: feeling unusually sleepy or fatigued.
• Dizziness: light‑headed sensation or loss of balance.
• Vomiting: expulsion of stomach contents.
• Mild rash: skin redness or itching.

Serious or Rare Side Effects

• Respiratory depression: slowed breathing, potentially life‑threatening.
• Dependence or addiction: risk of misuse with prolonged exposure.
• Severe allergic reaction: swelling, hives, or anaphylaxis.
• Liver toxicity: elevated enzymes or hepatic injury, especially with overdose.
• Hypotension: marked drop in blood pressure.
• Seizures: rare convulsive episodes.

Before prescribing Kodipar, clinicians should consider several safety measures.

• Assess liver function: monitor patients with hepatic impairment or chronic alcohol use.
• Avoid in severe respiratory depression: contraindicated in patients with compromised breathing.
• Use caution with CNS depressants: may increase sedation when combined with alcohol or sedatives.
• Limit use in pregnancy: only if clearly needed after risk‑benefit assessment.
• Store at ambient temperature: keep in the original pack, protect from moisture.

Kodipar can interact with other medicines, requiring careful management.

Major Interactions (Avoid)

• Other opioids: additive risk of respiratory depression.
• CYP2D6 inhibitors (e.g., fluoxetine): may increase codeine plasma levels.
• Alcohol: enhances central nervous system depression.
• MAO inhibitors: risk of severe sedation or hypotension.
• Additional paracetamol‑containing products: potential hepatotoxicity.

Moderate Interactions (Monitor Closely)

• Benzodiazepines: increased sedation and drowsiness.
• Antihistamines: additive CNS depressant effects.
• Tricyclic antidepressants: may raise seizure threshold.
• Anticoagulants: monitor bleeding if liver function is affected.
• Diuretics: possible alteration of renal clearance.